Clinical Trials in Pennsylvania

Showing 3081-3100 of 9,383 trials

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

NCT02432807

This is a Phase 3 study to evaluate the safety and efficacy of a vancomycin hydrochloride ophthalmic ointment dosed 4 times daily for 7 days compared to placebo (vehicle) in patients with moderate to severed Gram-positive bacterial conjunctivitis.

Bacterial Conjunctivitis

Kurobe LLC303 participantsStarted May 2015

Paramount, California, United States • Petaluma, California, United States • Rancho Cordova, California, United States +13 more locations

Active Not RecruitingPhase 1/295 miles

Durvalumab and Tremelimumab for Pediatric Malignancies

NCT03837899

The purpose of the study is to determine the recommended dose of durvalumab and tremelimumab (immunotherapy drugs) in pediatric patients with advanced solid and hematological cancers and expand in a second phase to test the efficacy of these drugs once this dose is determined.

Pediatric CancerSolid Tumor PediatricHematological Malignancies

AstraZeneca50 participantsStarted Mar 2019

Baltimore, Maryland, United States • Boston, Massachusetts, United States • New Hyde Park, New York, United States +16 more locations

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Durvalumab and Tremelimumab for Pediatric Malignancies

Find Trials by Condition in Pennsylvania

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

A Dose Determination and Safety Study of X4P-001 (Mavorixafor) in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms